Toni Choueiri in Milford, Massachusetts

Home Massachusetts Milford

Toni Choueiri has Medical Oncology as his primary medical specialty. Their primary office is: 20 Prospect St in Milford, Massachusetts. There is an additional office location, for a total of two, for Toni Choueiri that can be viewed further down.

They're a part of the: Dana-farber Cancer Institute, Inc. medical group which has around 542 members. You can call their office at 508-473-1190 to schedule an appointment. They also accept the Medicare-approved amount as payment in full. They attended Sorry, his university is not listed and graduated in 2000 (around 24 years of experience). They are not listed as doing telehealth appointments, but this may have changed. It can't hurt to call and check. If anything it may encourage them to make them available if they are not currently.

Toni K Choueiri Office Phone and Directions

Toni Choueiri
Dana-farber Cancer Institute, Inc.
20 Prospect St
Milford, Massachusetts 01757
508-473-1190

Patient Ratings
Please rate your experience with Toni Choueiri below to help others make a more informed decision. Thanks!

Current Rating: Loading...

Phone: 508-473-1190

Enter a starting address:

Healthcare Info for Toni Choueiri

Additional Medical Specialties Include:
INTERNAL MEDICINE

Medical School: Sorry, his university is not listed
Graduation Year: 2000
The Primary Medical Specialty for Toni Choueiri is listed as: Medical Oncology
Approximate Years of Experience: 24
PAC (PECOS ID)#: 5597857219
NPI #: 1073677209
NPI Created On: 12/21/2006
NPI Last Updated Listed as: 11/16/2011
Primary Taxonomy Code: 207RX0202X
License Number:
230658
Listed Gender: Male

Insurance, Services, Charges

Forms of insurance accepted by include, but are not limited to:

Harvard Pilgrim Health Care Inc.
Medicare

They are listed as accepting new patients.

Services and Procedures include:

Established patient office or other outpatient, visit typically 25 minutes
Physician telephone patient service, 21-30 minutes of medical discussion

They took part in Medicare's Electronic Health Record Incentive Program which was designed to help move people over to electronic records and improve the systems that were already in place.

Open Payments Data. This can include items to test (Durable Medical Equipment (DME)), Biological, Drug Samples, etc. This data must be reported to CMS.

Payments Total: $2,160

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 787623413

Being Disputed:: No

Product Related: No

Payments Total: $2,275

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 783476359

Being Disputed:: No

Product Related: Yes

Drug or Biological: Biological

Product Category #1: Oncology

Name of Drug #1: OPDIVO

Open Associated Drug #1: 0003-3774-12

Payments Total: $4,500

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 848309583

Being Disputed:: No

Product Related: No

Payments Total: $3,500

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 848443889

Being Disputed:: No

Product Related: No

Payments Total: $3,000

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 848462375

Being Disputed:: No

Product Related: No

Payments Total: $750

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Context of payment:: Provided as part of a clinical research engagement.

Record ID:: 848479945

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: ONCOLOGY

Name of Drug #1: WELIREG

Open Associated Drug #1: 0006-5331-01

Payments Total: $2,500

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 848677179

Being Disputed:: No

Product Related: No

Payments Total: $272

Number of Payments:: 1

Form of Payment: In-kind items and services

Context of payment:: Concur Concur-688-13

Record ID:: 838873697

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: CABOMETYX

Open Associated Drug #1: 42388-024-26

Payments Total: $2,250

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Record ID:: 849152605

Being Disputed:: No

Product Related: No

Payments Total: $5,000

Number of Payments:: 1

Form of Payment: Cash or cash equivalent

Third party is a Charity:: No

Record ID:: 833766191

Being Disputed:: No

Product Related: Yes

Drug or Biological: Drug

Product Category #1: Oncology

Name of Drug #1: Lenvima

Open Associated Drug #1: 62856-710-30

Additional Office Locations

1. Dana-farber Cancer Institute, Inc.
450 Brookline Ave
Boston, MA 02215
Group Members: 542

Phone: 508-473-1190

Enter a starting address:

Medical Oncology Professionals in Milford

1.
Gregory Abel

20 Prospect St
Milford, MA
Dana-farber Cancer Institute, Inc.

2.
Anita Koshy

14 Prospect St
Milford, MA
Dana-farber Cancer Institute, Inc.

3.
Mark Awad

20 Prospect St
Milford, MA
Dana-farber Cancer Institute, Inc.

4.
Kimmie Ng

20 Prospect St
Milford, MA
Dana-farber Cancer Institute, Inc.

5.
Natalie Sinclair

20 Prospect St
Milford, MA
Dana-farber Cancer Institute, Inc.

6.
Alexi Wright

20 Prospect St
Milford, MA
Dana-farber Cancer Institute, Inc.

Providers in Dana-farber Cancer Institute, Inc.

1.Gregory Abel

20 Prospect St
Milford Ma 01757-3042
Dana-farber Cancer Institute, Inc.
Medical Oncology

2.Gregory Abel

450 Brookline Ave
Boston Ma 02215-5418
Dana-farber Cancer Institute, Inc.
Medical Oncology

3.Janet Abrahm

75 Francis St
Boston Ma 02115-6110
Dana-farber Cancer Institute, Inc.
Internal Medicine

4.Janet Abrahm

450 Brookline Ave
Boston Ma 02215-5418
Dana-farber Cancer Institute, Inc.
Internal Medicine

5.Thomas Abrams Md

22 Patriot Pl
Foxborough Ma 02035-1375
Dana-farber Cancer Institute, Inc.
Medical Oncology

6.Thomas Abrams Md

75 Francis St
Boston Ma 02115-6110
Dana-farber Cancer Institute, Inc.
Medical Oncology

View all 542 members of Dana-farber Cancer Institute, Inc. medical group